A has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
A has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
As of today, Agilent Technologies's Trailing 12-Month Free Cash Flow is $1,312 Mil, and Market Cap is $34,426 Mil. Therefore, Agilent Technologies's FCF Yield % for today is 3.81%.
The historical rank and industry rank for Agilent Technologies's FCF Yield % or its related term are showing as below:
During the past 13 years, the highest FCF Yield % of Agilent Technologies was 4.84%. The lowest was 1.51%. And the median was 3.35%.
Agilent Technologies's FCF Margin % for the quarter that ended in Jan. 2025 was 19.87%.
The historical data trend for Agilent Technologies's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Agilent Technologies Annual Data | |||||||||||||||||||||
Trend | Oct15 | Oct16 | Oct17 | Oct18 | Oct19 | Oct20 | Oct21 | Oct22 | Oct23 | Oct24 | |||||||||||
FCF Yield % | Get a 7-Day Free Trial |
![]() |
![]() |
2.57 | 2.73 | 2.50 | 4.88 | 3.69 |
Agilent Technologies Quarterly Data | ||||||||||||||||||||
Apr20 | Jul20 | Oct20 | Jan21 | Apr21 | Jul21 | Oct21 | Jan22 | Apr22 | Jul22 | Oct22 | Jan23 | Apr23 | Jul23 | Oct23 | Jan24 | Apr24 | Jul24 | Oct24 | Jan25 | |
FCF Yield % | Get a 7-Day Free Trial |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
4.14 | 2.30 | 3.54 | 4.18 | 3.09 |
For the Diagnostics & Research subindustry, Agilent Technologies's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Diagnostics & Research industry and Healthcare sector, Agilent Technologies's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Agilent Technologies's FCF Yield % falls into.
FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
Agilent Technologies's FCF Yield % for the fiscal year that ended in Oct. 2024 is calculated as
FCF Yield % | = | Free Cash Flow | / | Market Cap |
= | 1373 | / | 37163.49983 | |
= | 3.69% |
Agilent Technologies's annualized FCF Yield % for the quarter that ended in Jan. 2025 is calculated as
FCF Yield % | = | Free Cash Flow | * | Annualized Factor | / | Market Cap |
= | 334 | * | 4 | / | 43218.35264 | |
= | 3.09% |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Agilent Technologies FCF Yield % Explanation
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Thank you for viewing the detailed overview of Agilent Technologies's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.
Rodney Gonsalves | officer: V.P., Corporate Controller | 5301 STEVENS CREEK BLVD., SANTA CLARA CA 95051 |
Sue H. Rataj | director | C/O CABOT CORPORATION, TWO SEAPORT LANE, SUITE 1300, BOSTON MA 02210 |
Padraig Mcdonnell | officer: Senior Vice President | 5301 STEVENS CREEK BLVD, SANTA CLARA CA 95051 |
Dominique Grau | officer: Senior Vice President | 5301 STEVENS CREEK BLVD., SANTA CLARA CA 95051 |
Philip Binns | officer: Senior Vice President | 5301 STEVENS CREEK BLVD., SANTA CLARA CA 95051 |
Michael R. Mcmullen | officer: CEO and President | 5301 STEVENS CREEK BLVD., MS 1A-LC, SANTA CLARA CA 95051 |
Heidi Fields | director | 5301 STEVENS CREEK BLVD, MS 1A-LC, SANTA CLARA CA 95051 |
Henrik Ancher-jensen | officer: Sr. Vice President | 5301 STEVENS CREEK BLVD., SANTA CLARA CA 95051 |
George A Scangos | director | C/O EXELIXIS INC, 170 HARBOR WAY, SAN FRANCISCO CA 94083 |
Otis W Brawley | director | 5203 BRISTOL INDUSTRIAL WAY, BUFORD GA 30518 |
Mikael Dolsten | director | 5 GIRALDA FARMS, MADISON NJ 07940 |
Mala Anand | director | C/O COTIVITI HOLDINGS, INC., 115 PERIMETER CENTER PLACE, SUITE 700, ATLANTA GA 30346 |
Dow R Wilson | director | VARIAN MEDICAL SYSTEMS INC, 3100 HANSEN WAY MAIL STOP E327, PALO ALTO CA 94304 |
Boon Hwee Koh | director | C/O AGILENT TECHNOLOGIES, 5301 STEVENS CREEK BLVD, MS 1A-LC, SANTA CLARA CA 95051 |
Hans Edgar Bishop | director | 60 WEST 66TH STREET, 26A, NEW YORK NY 10023 |
From GuruFocus
By GuruFocus News • 01-24-2025
By Business Wire • 01-24-2025
By Business Wire • 12-19-2024
By Business Wire • 03-10-2025
By GuruFocus News • 02-27-2025
By GuruFocus News • 02-27-2025
By GuruFocus News • 02-28-2025
By GuruFocus News • 02-27-2025
By Business Wire • 03-19-2025
By GuruFocus News • 02-26-2025
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.